Literature DB >> 19192036

Mitochondrial medicine: entering the era of treatment.

S Koene1, J Smeitink.   

Abstract

Research of patients with defects in cellular energy metabolism (mitochondrial disease) has led to a better understanding of mitochondrial biology in health and disease. The obtained knowledge is of increasing importance for physicians of all medical disciplines. It assists in enabling the development of rational treatment strategies for diseases or conditions caused by mitochondrial dysfunction. The still frequently used classical interventions with vitamins or co-factors are only beneficial in some rare mitochondrial disease conditions, like coenzyme Q biosynthesis defects. For that reason alternative strategies to correct disturbed energy metabolism have to be developed. New approaches in this direction include nutrition and exercise therapies, alternative gene expression, enzyme-replacement, scavenging of potentially toxic compounds and modulating cell signalling. The effect of some of these interventions has already been explored in humans whilst others are still at the level of single cell research. We review the state of the art of the development of mitochondrial treatment strategies and discuss what steps need to be taken to efficiently approach the huge burden of disease caused by dysfunctional mitochondria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192036     DOI: 10.1111/j.1365-2796.2008.02058.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  27 in total

Review 1.  Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.

Authors:  Hélène Cwerman-Thibault; José-Alain Sahel; Marisol Corral-Debrinski
Journal:  J Inherit Metab Dis       Date:  2010-06-23       Impact factor: 4.982

Review 2.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

4.  Problems of adults with a mitochondrial disease - the patients' perspective: focus on loss.

Authors:  Greet Noorda; Theo van Achterberg; Truus van der Hooft; Jan Smeitink; Lisette Schoonhoven; Baziel van Engelen
Journal:  JIMD Rep       Date:  2012-02-24

5.  Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Arwin M Valencia; Douglas R Lazzaro; Fayez Bany-Mohammed; Jacob V Aranda
Journal:  React Oxyg Species (Apex)       Date:  2017-01

Review 6.  Mitochondrial quality control in cardiac cells: Mechanisms and role in cardiac cell injury and disease.

Authors:  Farzaneh G Tahrir; Dianne Langford; Shohreh Amini; Taha Mohseni Ahooyi; Kamel Khalili
Journal:  J Cell Physiol       Date:  2018-11-11       Impact factor: 6.384

Review 7.  Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies.

Authors:  Paulien Smits; Jan Smeitink; Lambert van den Heuvel
Journal:  J Biomed Biotechnol       Date:  2010-04-13

8.  Signaling pathway networks mined from human pituitary adenoma proteomics data.

Authors:  Xianquan Zhan; Dominic M Desiderio
Journal:  BMC Med Genomics       Date:  2010-04-28       Impact factor: 3.063

9.  Do alterations in mitochondrial DNA play a role in breast carcinogenesis?

Authors:  Thomas E Rohan; Lee-Jun Wong; Tao Wang; Jonathan Haines; Geoffrey C Kabat
Journal:  J Oncol       Date:  2010-06-06       Impact factor: 4.375

Review 10.  Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Authors:  Valerian E Kagan; Peter Wipf; Detcho Stoyanovsky; Joel S Greenberger; Grigory Borisenko; Natalia A Belikova; Naveena Yanamala; Alejandro K Samhan Arias; Muhammad A Tungekar; Jianfei Jiang; Yulia Y Tyurina; Jing Ji; Judith Klein-Seetharaman; Bruce R Pitt; Anna A Shvedova; Hülya Bayir
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.